Signal Genetics (SGNL) Tops Q2 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. SPY
9. SBUX
10. AXP

Go back to Signal Genetics (SGNL) Tops Q2 EPS by 6c

Signal Genetics Highlights Recent Achievements and Reports Second Quarter 2015 Financial Results

August 12, 2015 4:32 PM EDT

Signed Master Service Agreement With Leading Pharmaceutical Company Record Volume of MyPRS® Tests Sold to Hospitals Outside of the University of Arkansas for Medical Sciences (UAMS)

CARLSBAD, Calif., Aug. 12, 2015 (GLOBE NEWSWIRE) -- Signal Genetics, Inc. (NASDAQ: SGNL) (Signal), a commercial stage, molecular genetics diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer, today reported recent achievements and financial results for the second quarter ended June 30, 2015.

Recent Highlights

Announced Master Service... More

Signal Genetics Highlights Recent Achievements and Reports Second Quarter 2015 Financial Results

August 12, 2015 4:32 PM EDT

Signed Master Service Agreement With Leading Pharmaceutical Company Record Volume of MyPRS® Tests Sold to Hospitals Outside of the University of Arkansas for Medical Sciences (UAMS)

CARLSBAD, Calif., Aug. 12, 2015 (GLOBE NEWSWIRE) -- Signal Genetics, Inc. (NASDAQ: SGNL) (Signal), a commercial stage, molecular genetics diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer, today reported recent achievements and financial results for the second quarter ended June 30, 2015.

Recent Highlights

Announced Master Service... More